Germany
Japan
United Kingdom
China
Antibodies
View as table Download
SEC14 like protein 2 (SEC14L2) (N-term) rabbit polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Bovine, Mouse, Rabbit, Rat |
| Immunogen | KLH conjugated synthetic peptide between 41-69 amino acids from the N-terminal region of Human SEC14L2 |
Rabbit Polyclonal Antibody against STAT3 (Phospho-STAT3-Y727 ) (Phospho-Specific)
| Applications | IF, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This STAT3 Antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide corresponding to amino acid residues surrounding S727 of human STAT3. |
| Modifications | Phospho-specific |
Rabbit Polyclonal Antibody against MEF2C (S387)
| Applications | IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This MEF2C antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 365-394 amino acids from human MEF2C. |
Rabbit polyclonal anti-POLR2C antibody (C-term)
| Applications | WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This POLR2C antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 200-228 amino acids from the C-terminal region of human POLR2C. |
c-Myc (MYC) chicken polyclonal antibody, Aff - Purified
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human |
| Immunogen | Synthetic peptide containing the Human c-myc epitope (i.e., EQKLISEEDL) conjugated to KLH. The first injection included complete Freund's adjuvant; subsequent injections included incomplete Freund's adjuvant. Eggs were collected after the fourth injection, and antibodies were purified from the yolks using a proprietary method that yields a purity of >90%. |
Rabbit Polyclonal Antibody against SOX2 (N-term)
| Applications | FC, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This SOX2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 89-119 amino acids from the N-terminal region of human SOX2. |
Rabbit Polyclonal Antibody against MDM2 (C-term)
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | This Mdm2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 393-424 amino acids from the C-terminal region of human Mdm2. |
c-Myc (MYC) chicken polyclonal antibody, FITC
| Applications | ELISA, IF, IHC, WB |
| Reactivities | Human |
| Conjugation | FITC |
| Immunogen | Synthetic peptide containing the Human c-myc epitope (i.e., EQKLISEEDL) conjugated to KLH. After repeated injections, immune eggs were collected, from which the IgY fractions were prepared. |
RKHD3 (MEX3B) (N-term) rabbit polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Human |
| Immunogen | KLH conjugated synthetic peptide between 36-65 amino acids from the N-terminal region of human MEX3B |
ZNF263 (Center) rabbit polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Human |
| Immunogen | KLH conjugated synthetic peptide between 317-346 amino acids from the Central region of human ZNF263 |
Rabbit Polyclonal Antibody against EIF4E2 (N-term)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This EIF4E2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 12-41 amino acids from the N-terminal region of human EIF4E2. |
Rabbit Polyclonal Antibody against MYST2 (N-term)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This HBO1/MYST2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 99-130 amino acids from the N-terminal region of human HBO1/MYST2. |
Rabbit Polyclonal Antibody against ATOH1 (C-term)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This MATH1/HATH1/ATOH1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 323-354 amino acids from the C-terminal region of human MATH1/HATH1/ATOH1. |
Rabbit Polyclonal Antibody against ATOH1 (N-term)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This MATH1/HATH1/ATOH1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 78-109 amino acids from the N-terminal region of human MATH1/HATH1/ATOH1. |
Rabbit Polyclonal Antibody against PHB (C-term)
| Applications | WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This PHB1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 182-211 amino acids from the C-terminal region of human PHB1. |
LHX6 (N-term) rabbit polyclonal antibody, Aff - Purified
| Applications | IHC, WB |
| Reactivities | Human, Mouse |
| Immunogen | KLH conjugated synthetic peptide between 36-65 amino acids from the N-terminal region of human Lhx6. |
Glutaredoxin 2 (GLRX2) (C-term) rabbit polyclonal antibody, Purified
| Applications | FC, IHC, WB |
| Reactivities | Human, Mouse |
| Immunogen | GLRX2 antibody is generated from Rabbits immunized with a KLH conjugated synthetic peptide between 126~155 amino acids from the C-terminal region of Human GLRX2. |
IRX5 (C-term) rabbit polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Human, Mouse |
| Immunogen | KLH conjugated synthetic peptide between 454-483 amino acids from the C-terminal region of human IRX5 / IRXB2 |
Active filters
Isotypes
- Ig
Families
- Transcription Factors
Filter by
Category
Target Symbol
- MYC (5)
- MEF2C (3)
- ATOH1 (2)
- CCNH (2)
- ELL (2)
- IRF1 (2)
- KAT2A (2)
- KAT2B (2)
- KAT7 (2)
- LHX6 (2)
- MECOM (2)
- MED6 (2)
- MYOG (2)
- NCOA1 (2)
- NFKBIL1 (2)
- NR0B1 (2)
- PAX7 (2)
- PHB (2)
- PIAS1 (2)
- SUMO1 (2)
- TGIF1 (2)
- TNFRSF1A (2)
- TP53 (2)
- ACAD8 (1)
- AEBP1 (1)
- AFF4 (1)
- AKAP17A (1)
- AR (1)
- ARX (1)
- ASCL2 (1)
- ATF3 (1)
- ATF4 (1)
- ATF5 (1)
- ATF6 (1)
- ATXN3 (1)
- BACH1 (1)
- BACH2 (1)
- BARX1 (1)
- BATF (1)
- BCL11A (1)
- BCL3 (1)
- BCL6 (1)
- BCLAF1 (1)
- BHLHE40 (1)
- BRF1 (1)
- BTF3 (1)
- BTG2 (1)
- CARM1 (1)
- CBX2 (1)
- CBX8 (1)
- CBY1 (1)
- CCNC (1)
- CCNT1 (1)
- CDX2 (1)
- CEBPD (1)
- CEBPG (1)
- CELF3 (1)
- CITED2 (1)
- CNOT3 (1)
- CNOT4 (1)
- CNOT8 (1)
- CRABP2 (1)
- CREG1 (1)
- CREM (1)
- CRK (1)
- CSDE1 (1)
- CTNNB1 (1)
- CXXC1 (1)
- DEAF1 (1)
- DEK (1)
- DGCR6L (1)
- DLX6 (1)
- DNMT3L (1)
- DRG1 (1)
- DYRK1B (1)
- E2F2 (1)
- E2F7 (1)
- EIF4E2 (1)
- ELAVL2 (1)
- ELF3 (1)
- ELF4 (1)
- ELL2 (1)
- EPAS1 (1)
- ERCC8 (1)
- ETS1 (1)
- ETS2 (1)
- EYA1 (1)
- EYA4 (1)
- FGF10 (1)
- FOSL2 (1)
- FOXA1 (1)
- FOXC2 (1)
- FOXD4 (1)
- FOXI1 (1)
- FOXJ2 (1)
- FOXL1 (1)
- FOXL2 (1)
- FOXN1 (1)
- FOXN2 (1)
- GATA3 (1)
Reactivities
Antibody Hosts
Clonalities
Conjugates
Modifications
Pathways
- Pathways in cancer (28)
- MAPK signaling pathway (18)
- Cell cycle (17)
- Chronic myeloid leukemia (14)
- TGF-beta signaling pathway (13)
- Wnt signaling pathway (13)
- Colorectal cancer (11)
- Small cell lung cancer (11)
- Thyroid cancer (10)
- Bladder cancer (9)
- Endometrial cancer (9)
- Acute myeloid leukemia (8)
- Jak-STAT signaling pathway (8)
- Prostate cancer (8)
- Ubiquitin mediated proteolysis (8)
- Huntington's disease (7)
- Metabolic pathways (7)
- ErbB signaling pathway (6)
- Maturity onset diabetes of the young (6)
- Melanoma (6)
- Pancreatic cancer (6)
- Renal cell carcinoma (6)
- Adipocytokine signaling pathway (5)
- Purine metabolism (5)
- Pyrimidine metabolism (5)
- RNA polymerase (5)
- Amyotrophic lateral sclerosis (ALS) (4)
- Apoptosis (4)
- Basal cell carcinoma (4)
- Glioma (4)
- Neurotrophin signaling pathway (4)
- Non-small cell lung cancer (4)
- Notch signaling pathway (4)
- RNA degradation (4)
- Adherens junction (3)
- Alzheimer's disease (3)
- Cytokine-cytokine receptor interaction (3)
- DNA replication (3)
- Melanogenesis (3)
- Nucleotide excision repair (3)
- Oocyte meiosis (3)
- PPAR signaling pathway (3)
- p53 signaling pathway (3)
- Antigen processing and presentation (2)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (2)
- Chemokine signaling pathway (2)
- Dorso-ventral axis formation (2)
- Endocytosis (2)
- Focal adhesion (2)
- Insulin signaling pathway (2)
- Regulation of actin cytoskeleton (2)
- Ribosome (2)
- Tight junction (2)
- Allograft rejection (1)
- Autoimmune thyroid disease (1)
- Basal transcription factors (1)
- Cell adhesion molecules (CAMs) (1)
- Circadian rhythm - mammal (1)
- Cysteine and methionine metabolism (1)
- Dilated cardiomyopathy (1)
- Fc gamma R-mediated phagocytosis (1)
- GnRH signaling pathway (1)
- Graft-versus-host disease (1)
- Hypertrophic cardiomyopathy (HCM) (1)
- Leukocyte transendothelial migration (1)
- Long-term depression (1)
- Long-term potentiation (1)
- Lysine degradation (1)
- Pathogenic Escherichia coli infection (1)
- Primary immunodeficiency (1)
- Progesterone-mediated oocyte maturation (1)
- Spliceosome (1)
- Type I diabetes mellitus (1)
- Valine (1)
- Viral myocarditis (1)
- leucine and isoleucine degradation (1)
- mTOR signaling pathway (1)